Yamamoto H - Search Results

1

Telomerase activity in normal human epithelial cells.

Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T, Utakoji T. Yasumoto S, et al. Among authors: yamamoto h. Oncogene. 1996 Jul 18;13(2):433-9. Oncogene. 1996. PMID: 8710384

2

Disorder in ultrastructure of basement membrane and mechanical junction in human esophageal cancer.

Imamoto H, Shiozaki H, Tahara H, Yano T, Yamamoto H, Kobayashi K, Tamura S, Mori T. Imamoto H, et al. Among authors: yamamoto h. Med J Osaka Univ. 1994 Sep;43(1-4):23-8. Med J Osaka Univ. 1994. PMID: 7609707

3

The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain.

Yamamoto H, Lamphier MS, Fujita T, Taniguchi T, Harada H. Yamamoto H, et al. Oncogene. 1994 May;9(5):1423-8. Oncogene. 1994. PMID: 8152803

4

Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells.

Yamamoto H, Soh JW, Shirin H, Xing WQ, Lim JT, Yao Y, Slosberg E, Tomita N, Schieren I, Weinstein IB. Yamamoto H, et al. Oncogene. 1999 Jan 7;18(1):103-15. doi: 10.1038/sj.onc.1202269. Oncogene. 1999. PMID: 9926925

5

NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.

Kikuchi H, Ozaki T, Furuya K, Hanamoto T, Nakanishi M, Yamamoto H, Yoshida K, Todo S, Nakagawara A. Kikuchi H, et al. Among authors: yamamoto h. Oncogene. 2006 Dec 7;25(58):7608-17. doi: 10.1038/sj.onc.1209748. Epub 2006 Sep 4. Oncogene. 2006. PMID: 16953234

6

ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin.

Yoshida K, Ozaki T, Furuya K, Nakanishi M, Kikuchi H, Yamamoto H, Ono S, Koda T, Omura K, Nakagawara A. Yoshida K, et al. Among authors: yamamoto h. Oncogene. 2008 Feb 14;27(8):1183-8. doi: 10.1038/sj.onc.1210722. Epub 2007 Aug 13. Oncogene. 2008. PMID: 17700524

7

Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP.

Yamamoto H, Kihara-Negishi F, Yamada T, Hashimoto Y, Oikawa T. Yamamoto H, et al. Oncogene. 1999 Feb 18;18(7):1495-501. doi: 10.1038/sj.onc.1202427. Oncogene. 1999. PMID: 10050886

8

Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.

Shimozato O, Waraya M, Nakashima K, Souda H, Takiguchi N, Yamamoto H, Takenobu H, Uehara H, Ikeda E, Matsushita S, Kubo N, Nakagawara A, Ozaki T, Kamijo T. Shimozato O, et al. Among authors: yamamoto h. Oncogene. 2015 Apr 9;34(15):1949-60. doi: 10.1038/onc.2014.141. Epub 2014 Jun 2. Oncogene. 2015. PMID: 24882578

9

In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.

Kihara-Negishi F, Yamamoto H, Suzuki M, Yamada T, Sakurai T, Tamura T, Oikawa T. Kihara-Negishi F, et al. Among authors: yamamoto h. Oncogene. 2001 Sep 20;20(42):6039-47. doi: 10.1038/sj.onc.1204756. Oncogene. 2001. PMID: 11593411

10

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.

Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K. Iwata N, et al. Among authors: yamamoto h. Oncogene. 2000 Nov 2;19(46):5298-302. doi: 10.1038/sj.onc.1203898. Oncogene. 2000. PMID: 11077447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,272 results

Search Page

Filters